Annual Dialysis Conference > Articles by: mimhav

Author: mimhav

By mimhav

Outset Medical

Outset Medical is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System is an enterprise solution approved for use across the entire continuum of care — from hospital to home, allowing dialysis to be delivered anytime, anywhere, by anyone.

website: outsetmedical.com

By mimhav

NephU

NephU – Through increased awareness, collaboration, and information-sharing, our mission is to improve the future outcomes for individuals with kidney disease and other related conditions. NephU offers your organization private, in-person and virtual educational programs on a range of kidney health topics. future outcomes for individuals with kidney disease and other related conditions.

website: https://nephu.org/

By mimhav

Vifor Pharma

Vifor Pharma Group is a global pharmaceutical company. It aims to become the global leader in iron deficiency, nephrology, and cardio-renal therapies. The company is the partner of choice for pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives.

website: https://www.viforpharma.com/

By mimhav

ADC Speaker and Moderator Zoom Training 2022

Speaker Slides are Due on February 1st for CME application

Please send slides to conferences@mimh.edu with ADC2022 in the subject line by Tuesday, February 1, 2022. Thank you!

ADC Slide Guide

      • All presentations must be compatible with PowerPoint
      • All presentations must be submitted prior to February 1st, 2022
      • Slides should not have any commercial information, institutional affiliations are ok to use
      • Please submit symbols as words. Use standard abbreviations and generic drug names
      • Include references slide

Thank you for speaking at the Annual Dialysis Conference this year. Since this is a virtual conference, we would like to invite you to attend a training for speakers and moderators on how the virtual program will run. You will be using the Zoom application to present from and the training will help you get familiar with the program and how the ADC virtual program will be handled this year.

Below are the dates for training, please choose to attend one, and use the links below to connect.
Speaker Trainings
Tuesday, February 8, at 4 pm Central – 
Moderator Trainings
Tuesday, February 1, at 3 pm Central – 
Monday, February 7, at 6 pm Central – 
The training should not last more than 30 minutes, but we have allowed 1 hour in case of questions or other issues.
If you cannot make a session, you can watch a previously recorded training.
Click Here to download the speaker training slides.
If none of the above dates work, please contact me at Kelly.Gregory@mimh.edu and we will try to accommodate.
Thank you for your participation.
ADC Planning Committee
…
By mimhav

Fellows Forum

Fellows Forum

4:00-6:00 pm

Moderator:  Shweta Bansal, MD

Judges: Finnian R. McCausland, MD, Shweta Bansal, MD, Nupur Gupta, MD

4:00-4:10              Introduction

4:10-4:20            Miraculous Recovery of Kidney Function after 16 Months of Dialysis – Hanny Sawaf, MD

4:20-4:25              Questions

4:25-4:35            Peritoneal Dialysis Related Encapsulating Sclerosing Peritonitis – Amara Sarwal, MD

4:35-4:40              Questions

4:40-4:50              A Rare Case of Bacterial Peritonitis Caused by Ralstonia Mannitolilytica in an Adult Peritoneal Dialysis Patient – Litty Thomas, MD

4:50-4:55              Questions

4:55-5:05              Guillain-Barre Syndrome Following COVID-19 in a Patient on Peritoneal Dialysis – Victor Canela, MD

5:05-5:10              Questions

5:10-5:15            All In One – Rapid Progression of Diabetic Nephropathy, Access Problems in the Form of CRBSI, Fibrin Sheath and Thrombosis of Catheter Tip, Primary Failure of AV Fistulae – Chilaka Rajesh, MD

5:15-5:20              Questions

5:20-5:30              Clinical Challenges to Prescribe Effective Hemodialysis in a Patient with Advance Liver Cirrhosis – Manoj Datta, MD  

5:30-5:35            Questions

5:35-5:45              Judges Convene

5:45                        Announce Winner/Adjourn

By mimhav

Akebia Therapeutics

Founded in 2007, Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. As a leader in the renal community, we leverage scientific expertise and commercial capabilities to deliver unique therapeutics to address the complications of kidney disease.   We are located in the biotech hub of Kendall Square in Cambridge, Massachusetts, where we are inspired by our peers and dedicated to working with our partners, patients, advocacy organizations and the broader renal community. We have both a commercially available product, and a late-stage candidate for the potential treatment of anemia due to CKD.

website: https://www.akebia.com/